Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assem... Read more
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
161 followers
Regeneron
132 followers
Illumina
79 followers
Agilent Technologies
82 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
45 followers
Explore companies